E-LIB Suche - Ergebnisse für: Monkhorst, K

1

Optimising primary molecular profiling in non-small cell lu..:

Schouten, R. D. ; Schouten, I. ; Schuurbiers, M. M. F....
PLOS ONE. 19 (2024) 7 - p. e0290939 , 2024

Link: https://doi.org/10.1371/..

2

ESMO Recommendations on clinical reporting of genomics test..:

van de Haar, J. ; Roepman, P. ; Andre, F....
Annals of Oncology. , 2024

Link: https://doi.org/10.1016/..

3

P2.10-07 ORA-LM: Molecular Analysis in Cerebrospinal Fluid ..:

van der Wel, T. ; Boelens, M.C. ; Jebbink, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S354-S355 , 2023

Link: https://doi.org/10.1016/..

4

191P ROS1 fusions in resected stage I-III adenocarcinoma (A..:

Speel, E-J.M. ; Radonic, T. ; Dafni, U....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S144-S145 , 2023

Link: https://doi.org/10.1016/..

5

Trastuzumab-Emtansine and Osimertinib Combination Therapy t..:

Jebbink, M. ; de Langen, A.J. ; Monkhorst, K....
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100481 , 2023

Link: https://doi.org/10.1016/..

6

MA16.03 Tremelimumab plus Durvalumab Prior to Chemoradiothe..:

Smeenk, M.M. ; van Diessen, J.N.A. ; Boellaard, T.N....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S157 , 2023

Link: https://doi.org/10.1016/..

7

EP13.05-02 Temozolomide-associated Hypermutation and Respon..:

Buikhuisen, W. ; Badrising, S. ; Derks, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S701 , 2023

Link: https://doi.org/10.1016/..

8

Effective generation of tumor-infiltrating lymphocyte produ..:

Castenmiller, S.M. ; de Groot, R. ; Guislain, A....
Immuno-Oncology and Technology. 15 (2022) - p. 100090 , 2022

Link: https://doi.org/10.1016/..

9

Complete genomic characterization in patients with cancer o..:

Schipper, L.J. ; Samsom, K.G. ; Snaebjornsson, P....
ESMO Open. 7 (2022) 6 - p. 100611 , 2022

Link: https://doi.org/10.1016/..

10

40P Can we predict which TIL products will react against NS..:

Castenmiller, S. ; Kanagasabesan, N. ; de Groot, R....
Immuno-Oncology and Technology. 16 (2022) - p. 100145 , 2022

Link: https://doi.org/10.1016/..

11

The role of surgery in the treatment of oligoprogression af..:

Joosten, P.J.M. ; de Langen, A.J. ; van der Noort, V....
Lung Cancer. 161 (2021) - p. 141-151 , 2021

Link: https://doi.org/10.1016/..

12

Presence of a 34-gene signature is a favorable prognostic m..:

Theelen, W. S. M. E. ; Krijgsman, O. ; Monkhorst, K....
Journal of Translational Medicine. 18 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

13

Osimertinib treatment for patients with EGFR exon 20 mutati..:

van Veggel, B. ; Madeira R Santos, J.F. Vilacha ; Hashemi, S.M.S....
Lung Cancer. 141 (2020) - p. 9-13 , 2020

Link: https://doi.org/10.1016/..

14

The force of HER2 – A druggable target in NSCLC?:

Jebbink, M. ; de Langen, A.J. ; Boelens, M.C...
Cancer Treatment Reviews. 86 (2020) - p. 101996 , 2020

Link: https://doi.org/10.1016/..

15

ALK immunohistochemistry positive, FISH negative NSCLC is i..:

Thunnissen, E. ; Lissenberg-Witte, B.I. ; van den Heuvel, M.M....
Lung Cancer. 138 (2019) - p. 13-18 , 2019

Link: https://doi.org/10.1016/..